iiinova — where your digital self keeps evolving

Reposted by Ashwin Sachdeva

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 18/11/2025

Could zoledronic acid lower fracture risk in advanced hormone-sensitive #ProstateCancer? @asachdeva.bsky.social & team @manchester.ac.uk, funded by our Movember FASTMAN Centre of Excellence, share their analysis in Annals of Oncology. Grab a ☕ & read: doi.org/10.1016/j.an...

Scientific Paper published in Annals of Oncology, titled: Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data. Written by Jones et al.

021

Reposted by Ashwin Sachdeva

Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 24/09/2025

Exciting news - we are recruiting new Group Leaders! 🥼 We are seeking to appoint exceptional early-career scientists & clinician scientists as #GroupLeaders to develop bold, innovative, high-impact #CancerResearch programmes Full details on our website: www.cruk.manchester.ac.uk/career/new-g...

youtu.be

Group Leader Recruitment at the Cancer Research UK Manchester Institute

YouTube video by CRUK Manchester Institute

42118

Reposted by Ashwin Sachdeva

UoM Division of Cancer Sciences @uom-dcs.bsky.social · 07/04/2025

Come along later later this week👇 when we have the next installment of our internal DCS Postdoc and PhD seminar series 🥼 Kirsten Tinsley (Prof Angeliki Malliri's lab) 🧫 Dr Struan Gray (Prof Noel Clarke & Dr Ashwin Sachdeva's lab) 📍 Michael Smith Lecture Theatre 📅 Thursday 10th April ⏰ 1-2pm

013

Reposted by Ashwin Sachdeva

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 31/03/2025

[1/7] Let’s take a closer look at the new data on quantum cascade laser (QCL) microscopy in #ProstateCancer, published this week by Dr Dougal Ferguson, @asachdeva.bsky.social, Prof Peter Gardner and the team at the University of Manchester 🧵.

122

Reposted by Ashwin Sachdeva

UCL Innovative Clinical Trials Unit @innovative-ctu.bsky.social · 25/03/2025

🎉Congratulations to our STAMPEDE clinical trial team for winning a NIHR Impact Prize! The multi-arm multi-stage STAMPEDE trial has tested 10 different treatment approaches for advanced #ProstateCancer, with an enormous impact on patients' life expectancy Read more 👉 buff.ly/0VdnmSx

173

Reposted by Ashwin Sachdeva

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 25/03/2025

Can quantum cascade laser microscopy acquire #prostatecancer data that's good enough and quick enough for diagnostic lab timeframes? Dr Dougal Ferguson, Prof Peter Gardner and team @uniofmanchester.bsky.social share their exciting new findings in @rsc.org Grab a ☕and read: doi.org/10.1039/D5AN...

Full fingerprint hyperspectral imaging of prostate cancer tissue microarrays within clinical timeframes using quantum cascade laser microscopy. Dougal Ferguson, Niels Kroeger-Lui, Domenic Dreisback, Claire Hart, Diego Sanchez, Pedro Oliveira, Mick Brown, Noel Clarke, Ashwin Sachdeva and Peter Gardner. Analyst Journal from the Royal Society of Chemistry.

022